L02AE01 buserelin
ATC group of level 5 – chemical substance · in plain English: hormone treatment of cancer
This site has the patient leaflet or the SPC of 3 medicines in this group.
- 1 prescription only (POM)
- 2 no longer supplied or not available
Active substance: Buserelin – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L02 Endocrine therapy antineoplastic and immunomodulating agents 131 medicines
- L02A Hormones and related agents 44 medicines
- L02AE Gonadotropin releasing hormone analogues, endocrine therapy drugs 29 medicines
- L02AE01 buserelin 3 medicines
- L02AE Gonadotropin releasing hormone analogues, endocrine therapy drugs 29 medicines
- L02A Hormones and related agents 44 medicines
- L02 Endocrine therapy antineoplastic and immunomodulating agents 131 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Suprecur 150 micrograms nasal spray SPC no longer supplied | – |
| Suprecur injection SPC | Prescription only (POM) |
| Suprefact 1 mg / ml injection SPC no longer supplied | – |
Other groups of the same level
- L02AE02 leuprorelin 17 medicines
- L02AE03 goserelin 4 medicines
- L02AE04 triptorelin 5 medicines
Other names of the ATC group
- French: L02AE01 buséréline
- German: L02AE01 Buserelin
- Spanish: L02AE01 BUSERELINA
- German: L02AE01 Buserelin
- Italian: L02AE01 BUSERELINA
- Polish: L02AE01 Buserelina
- Turkish: L02AE01 buserelin
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L02AE01
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.